Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Baricitinib helps long-term hair regrowth in severe alopecia areata patients.

Newer contraceptives with less androgenic progestins may reduce female hair loss.

Combining a GnRH agonist with a low-dose oral contraceptive is more effective and safer for treating hirsutism than using either alone.

High CCL11 levels may indicate poor response to baricitinib in severe alopecia areata.

Baicalin may help reduce excessive male hormone levels in PCOS.

Scientists made a carbon-14 labeled version of a drug with a 48% yield and over 99% purity.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Ponatinib can cause a rare skin reaction that resolves with topical treatment and temporary drug discontinuation.

Healthcare claims databases can help monitor drug safety, but may report adverse events differently than direct surveillance.

Baricitinib is effective and safe for treating severe alopecia areata, promoting significant hair regrowth.

Lifestyle changes are more effective than metformin for reducing type 2 diabetes risk.

Baricitinib helps with severe hair loss, negative-pressure therapy lowers hernia recurrence, tranexamic acid reduces bleeding, robot-assisted breast surgery may improve outcomes, and acellular dermal matrix could decrease breast reconstruction complications.

Cyproterone acetate reduced hair growth in most hirsute females and made hair softer, thinner, and lighter.

Dutasteride is more effective for male pattern baldness than finasteride, and black cohosh extract BNO 1055 is as effective as conjugated estrogens in treating postmenopausal symptoms, with added benefits in reducing sweating and mental symptoms.

Both treatments are similarly effective, but paclitaxel-carboplatin is cheaper and has more severe side effects.

Orlistat helped reduce weight and testosterone in obese women with PCOS but did not significantly affect other androgens or cholesterol levels.

Baricitinib helps with early hair regrowth in people with alopecia areata.

Presurgical models can effectively and affordably screen cancer prevention agents.

Cabergoline is more effective and has fewer side effects than bromocriptine for treating women with hyperprolactinemic amenorrhea.

Some medicines can reduce excessive hair growth in women, but more research is needed to compare treatments and consider side effects.

Adjusting minoxidil dosage may be safer than using bicalutamide for hair loss in women.

Progestogens are essential in menopausal hormone therapy to prevent uterine cancer and must be chosen carefully based on individual needs.

Ticagrelor works better than clopidogrel in reducing platelet activity in elderly patients with acute coronary syndrome.

Depo-Provera effectively prevents pregnancy but has many side effects and safety concerns, leading to its ban in the U.S.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

Oral contraceptives are generally recommended for healthy young girls, but specific types may vary based on individual health conditions and barrier methods are less popular among adolescents.

Dienogest and combined oral contraceptives are equally effective for endometriosis, but COC may reduce painful intercourse more.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

Combination therapy with oral contraceptives and spironolactone improves hair growth, menstrual issues, and acne in women with PCOS.